Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.
We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.
ITM Isotopen Technologien München would like to invite you to the Scientific Satellite Symposium “Challenges and Innovative Approaches in the Management of Osteoblastic Metastatic Disease” as part of the virtual EANM Congress 2020 on Friday October 23, 2020 from 16:55 - 18:25 (CET), on Channel 10.
Join us to discuss osteoblastic metastatic disease, management paradigms and future radiopharmaceutical treatment options chaired by Prof Andrei Iagaru, Palo Alto, CA, U.S. and the faculty of the renowned oncology and nuclear medicine experts Prof Robert E Coleman, University of Sheffield, Sheffield, UK, Prof Oliver Sartor, Tulane Cancer Center, New Orleans, LA, U.S. and Prof Wolfgang Weber, University Hospital rechts der Isar, Munich, Germany.
“Metastatic bone disease remains a significant factor in the morbidity and mortality of various cancers, including prostate. Recent advances in understanding the pathophysiology of osteoblastic bone metastases, as well as novel management paradigms and radiopharmaceuticals, create hope for significant improvements in patient care,” comments the symposium chair Prof Andrei Iagaru.
Look forward to a stimulating session with in-depth expert knowledge, practice experience and latest research results.
We hope to see you there!
Chair: Prof Andrei Iagaru
Stanford University Medical Center, Stanford, CA, U.S.
Welcome & Introduction
Prof Andrei Iagaru, Stanford University Medical Center, Stanford, CA, U.S.
Pathophysiology of Osteoblastic Metastatic Disease
Prof Robert E Coleman, University of Sheffield, Sheffield, UK (15 min)
Current and Future Management Paradigms for Metastatic Bone Disease in Castrate-Resistant Prostate Cancer
Prof Oliver Sartor, Tulane Cancer Center, New Orleans, LA, U.S. (15 min)
Future Radiopharmaceutical Treatment Options for Primary and Metastatic Bone Cancer
Prof Wolfgang Weber, University Hospital rechts der Isar, Munich, Germany (15 min)
Panel Discussion & Closing Remarks